The global phenylketonuria therapeutics market is poised for significant growth, projected to escalate from US$ 1 billion in 2023 to US$ 2.28 billion by 2033, with a robust compound annual growth rate (CAGR) of 8.6%. This forecast follows a growth pattern established from 2018 to 2022, during which the market experienced a CAGR of 5.2%. …
Tag Archives: Phenylketonuria Therapeutics Market
Phenylketonuria Therapeutics Sector Poised for 8.6% CAGR Augmentation by 2033, According to Future Market Insights Analysis
A genetic metabolic condition called Phenylketonuria Therapeutics Market affects how the body processes protein. Phenylalanine is an amino acid that patients with PKU are unable to effectively break down, which can result in the accumulation of harmful chemicals in the body. PKU can result in severe intellectual disabilities, convulsions, and other neurological issues if left …